Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia

Recruiting

Early Phase 1

Melatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing HypothermiaMelatonin as a Neuroprotective Therapy in Neonates With HIE Undergoing Hypothermia

Sponsor:

University of Florida

Code:

NCT02621944

Conditions

Hypoxic Ischemic Encephalopathy

Eligibility Criteria

Sex: All

Age: 0 - 6

Healthy Volunteers: Not accepted

Interventions

Melatonin

Magnetic Resonance Imaging

Pharmacokinetics

Neurological Outcome Assessment

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-30. This information was provided to ClinicalTrials.gov by University of Florida on 2024-08-21.